Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
A new study based on data from nearly 500 patients gives us some insight into how a selected group of men less than 50 years of age were thinking about treatment for prostate cancer between 2001 and 2005. Whether one would get the same results for a similar group of patient diagnosed today is a good [...]
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: choice, decision-making, influence, option, young | 2 Comments »
There is significant use of a variety of forms of complementary and alternative forms of medicine (CAM) among patients with localized prostate cancer. A new study in the Journal of Community Health has explored the prevalence and predictors of such behavior in a rural community setting.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: alternative, choice, complementary, quality of life | 1 Comment »
The need for patients diagnosed with early stage prostate cancer to be highly involved in the decision as to which form of management they wish to be given is well understood. However, there has been a relative dearth of data on why patients actually make their individual decisions.
Filed under: Diagnosis, Management, Treatment | Tagged: choice, first line, intermediate, localized, low, Management, patient, risk, Treatment | 2 Comments »
At urology clinics in three states in the USA, prostate cancer patients were asked, after diagnosis but before treatment, about their likes and dislikes of five common treatment options.
Filed under: Management, Treatment | Tagged: choice, option, Treatment | 4 Comments »
A group of Australian researchers has developed a statistical model that may help men to be able to make better choices about their need for prostate cancer screening. But not everyone is going to agree with this point of view! At the same time, an article in the BMJ by a team of Harvard epidemiologists [...]
Filed under: Diagnosis, Risk | Tagged: choice, PSA, screening, testing | 6 Comments »
Today’s news reports refer to a series of reviews that appeared this month in a supplement to Urology as well as other articles: 20 years of experience with the PSA test in assessment of risk for prostate cancer Biomarkers in the assessment of future risk for prostate cancer Treatment choice, outcome, and quality of life [...]
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: biomarkers, choice, Diagnosis, outcome, prognosis, PSA, quality of life, risk, survival, Treatment | Leave a Comment »
There are multiple news reports available today, including coverage of the following: Vegetable consumption and prostate cancer risk Anti-hypertensive medications and prostate cancer risk Prostate cancer incidence among South Indian and Pakistani immigrants to the United States Bladder neck contracture and type of surgery Cytotoxic and targeted chemotherapies in the managment of prostate cancer The [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention, Risk, Treatment | Tagged: anti-hypertensives, bladder neck contracture, chemotherapy, choice, cytotoxic, detection, immigrants, Indian, Pakistani, race, risk, targeted, USA, vegetables | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site